Mesenchymal stem cells or multipotent stromal cells (MSCs) isolated from the bone marrow
of adult organisms were initially characterized as plastic adherent, fibroblastoid cells with the …

Tissue-specific progenitor cells are characterized by proliferation and differentiation, but, in
contrast to embryonic stem (ES) cells, have limited capacities for self-renewal and no …

Adipose tissue-derived mesenchymal stem cells (AdMSCs) represent an attractive and
ethical cell source for stem cell therapy. With the recent demonstration of MSC homing …

Tissue engineering has recently become available as a treatment procedure for bone
augmentation. However, this procedure has several problems, such as high capital …

Glioblastoma (GBM) is the most common and malignant primary brain tumor in adults
associated with a poor survival. Current standard of care consists of surgical resection …

Spinal cord injury triggers irreversible loss of motor and sensory functions. Numerous
strategies aiming at repairing the injured spinal cord have been studied. Among them, the …

Mesenchymal stem cells (MSCs) can trans/differentiate to neural precursors and/or mature
neurons and promote neuroprotection and neurogenesis. The above could greatly benefit …

Human mesenchymal stem cells (MSCs) communicate with other cells in the human body
and appear to “home” to areas of injury in response to signals of cellular damage, known as …

Bone marrow mesenchymal stem cells (MSCs) can differentiate into several types of
mesenchymal cells, including osteocytes, chondrocytes, and adipocytes, but, under …

Background BM-derived mesenchymal stem cells (MSC) are attractive sources for
autotransplantation with no risk of rejection, but the use of these cells has problems …